MRSA continues to be a major concern in children, linked to complications and treatment failures despite its decreasing prevalence.
The review highlights various antibiotics, focusing on vancomycin as the go-to treatment for serious MRSA infections while calling for updated dosing and monitoring practices.
There’s a need for more research on the safety and efficacy of different antibiotics in children, and emerging treatments like phage therapy show promise for serious MRSA cases.